Transdermal selegiline for the treatment of major depressive disorder

Non-selective inhibition of monoamine oxidase (MAO) enzymes (ie, isoforms A and B) in the brain are associated with clinically significant antidepressant effects. In the US, the selegiline transdermal system (STS; EMSAM) is the first antidepressant transdermal delivery system to receive Food and Dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kelly C, Chen, Jack J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656289/
https://www.ncbi.nlm.nih.gov/pubmed/19300583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656289/
https://www.ncbi.nlm.nih.gov/pubmed/19300583

Ejemplares similares